P

Inventor

MILLS MARK

GB12 patents
⚠️ This page may combine multiple inventors who share the name “MILLS MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CORCEPT THERAPEUTICS INC

4 patents
US11787780B2Oct 17, 2023

Quaternary indazole glucocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC3 citations67
US12180186B2Dec 31, 2024

Quaternary indazole glucocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC0 citations57
US12098141B2Sep 24, 2024

Bicyclic indazole glucocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC0 citations48
US12098144B2Sep 24, 2024

Piperazine indazole glucocorticoid receptor antagonists

CORCEPT THERAPEUTICS INC0 citations46

HEWLETT PACKARD DEVELOPMENT CO

1 patent
US7779368B2Aug 17, 2010

Systems and methods for presenting managed data

HEWLETT PACKARD DEVELOPMENT CO20 citations91

MILLS MARK

1 patent
US4611358ASep 16, 1986

Device for tube cutting, reaming and bending

MILLS MARK16 citations62

ABBVIE INC

1 patent
US11993613B2May 28, 2024

Thiazolo[5,4-b]pyridine MALT-1 inhibitors

ABBVIE INC0 citations61

HEPTARES THERAPEUTICS LTD

1 patent
US12240825B2Mar 4, 2025

Oxexin 1 receptor antagonists

HEPTARES THERAPEUTICS LTD0 citations60

HEWLETT PACKARD ENTPR DEV LP

1 patent
US10452315B2Oct 22, 2019

Block priority information

HEWLETT PACKARD ENTPR DEV LP1 citations56

CELGENE INT II SARL

1 patent
US10034886B2Jul 31, 2018

GLP-1 receptor modulators

CELGENE INT II SARL1 citations50

NXERA PHARMA UK LTD

1 patent
US12331029B2Jun 17, 2025

Orexin 1 receptor antagonists

NXERA PHARMA UK LTD0 citations49

CELGENE INT II SÀRL

1 patent
US9795613B2Oct 24, 2017

GLP-1 receptor modulators

CELGENE INT II SÀRL1 citations49